Eventide Asset Management’s Avidity Biosciences RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.7M Hold
375,924
0.19% 123
2025
Q1
$11.1M Hold
375,924
0.22% 121
2024
Q4
$10.9M Hold
375,924
0.2% 130
2024
Q3
$17.3M Hold
375,924
0.3% 98
2024
Q2
$15.4M Buy
+375,924
New +$15.4M 0.26% 106